Literature DB >> 21162612

Clinical symptoms and survival in non-smoking and smoking HIV-negative patients with non-tuberculous mycobacterial isolation.

Hannele Kotilainen1, Ville Valtonen, Pentti Tukiainen, Tuija Poussa, Jussi Eskola, Asko Järvinen.   

Abstract

BACKGROUND: Non-tuberculous mycobacteria (NTM) cause infections in patients with smoking-related chronic lung diseases and also in non-smoking healthy elderly women. We analyzed the clinical symptoms, underlying diseases and mortality in patients with NTM culture findings, with special emphasis on smoking status.
METHODS: A total of 120 consecutive adult HIV-negative patients with NTM isolation were followed between 1990 and 1998 by retrieving data from their medical records for a period of at least 4 y, until 8 June 2006. Their clinical pictures and outcomes were analysed according to smoking status.
RESULTS: In this study, 42% of the patients had never smoked. Females accounted for 72% of non-smokers, but only 30% of smokers (p < 0.001). Mycobacterium avium complex (MAC) accounted for 72% of all isolates in non-smokers and 41% in smokers (p = 0.001). Furthermore, 28% of non-smokers and 19% of smokers had no previous pulmonary diseases (p = 0.223). In nearly half of all patients (48%), symptoms of NTM infection started within a year prior to NTM isolation. Smokers had a higher risk of mortality compared to non-smokers (hazard ratio 1.64, p = 0.049), though this was not found after adjusting for underlying diseases. No fatal underlying diseases were found for 82% of non-smokers and 59% of smokers (p < 0.01).
CONCLUSIONS: Non-smokers with NTM isolates had fewer previous lung diseases but had a higher incidence of MAC and bronchiectasis. Time from symptoms to NTM isolation was shorter than previously reported.

Entities:  

Mesh:

Year:  2010        PMID: 21162612     DOI: 10.3109/00365548.2010.535558

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Mortality among patients with pulmonary non-tuberculous mycobacteria disease.

Authors:  M Fleshner; K N Olivier; P A Shaw; J Adjemian; S Strollo; R J Claypool; L Folio; A Zelazny; S M Holland; D R Prevots
Journal:  Int J Tuberc Lung Dis       Date:  2016-05       Impact factor: 2.373

Review 2.  Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights.

Authors:  Pamela J McShane; Jeffrey Glassroth
Journal:  Chest       Date:  2015-12       Impact factor: 9.410

3.  Discovery of benzothiazole amides as potent antimycobacterial agents.

Authors:  James Graham; Christina E Wong; Joshua Day; Elizabeth McFaddin; Urs Ochsner; Teresa Hoang; Casey L Young; Wendy Ribble; Mary A DeGroote; Thale Jarvis; Xicheng Sun
Journal:  Bioorg Med Chem Lett       Date:  2018-08-25       Impact factor: 2.940

4.  Clinical findings in relation to mortality in non-tuberculous mycobacterial infections: patients with Mycobacterium avium complex have better survival than patients with other mycobacteria.

Authors:  H Kotilainen; V Valtonen; P Tukiainen; T Poussa; J Eskola; A Järvinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-09       Impact factor: 3.267

5.  Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.

Authors:  Hannele Kotilainen; Marja-Liisa Lokki; Riitta Paakkanen; Mikko Seppänen; Pentti Tukiainen; Seppo Meri; Tuija Poussa; Jussi Eskola; Ville Valtonen; Asko Järvinen
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

6.  Inventory study of non-tuberculous mycobacteria in the European Union.

Authors:  Marieke J van der Werf; Csaba Ködmön; Vera Katalinić-Janković; Tiina Kummik; Hanna Soini; Elvira Richter; Dimitrios Papaventsis; Enrico Tortoli; Monique Perrin; Dick van Soolingen; Manca Zolnir-Dovč; Vibeke Ostergaard Thomsen
Journal:  BMC Infect Dis       Date:  2014-02-06       Impact factor: 3.090

7.  Isolation of nontuberculous mycobacteria from soil using Middlebrook 7H10 agar with increased malachite green concentration.

Authors:  Yuli Hu; Xinglong Yu; Dun Zhao; Runcheng Li; Yang Liu; Meng Ge; Huican Hu
Journal:  AMB Express       Date:  2017-03-23       Impact factor: 3.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.